Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective Na(V)1.7 channel inhibitor shows promise as an analgesic

Aug. 28, 2012

Multiple novel CCR2 receptor antagonists synthesized at Janssen

Aug. 28, 2012

Abbott presents discovery of multiple HCV NS5B inhibitors

Aug. 27, 2012

Chugai presents new highly potent and selective AXL inhibitor

Aug. 27, 2012

New SPT inhibitor selected for further development in hepatitis C

Aug. 24, 2012

New BACE inhibitor reduces CNS beta-amyloid in vivo

Aug. 24, 2012

Amgen products target free fatty acid FFA1 receptor for diabetes

Aug. 24, 2012

Dual-action AT1 receptor antagonist/PPAR-gamma agonist selected as clinical candidate

Aug. 24, 2012

Takeda presents new potent IAP inhibitors with promising oncolytic activity

Aug. 23, 2012

HTS hit-to-lead discovery program yields new GSK-3 beta inhibitors

Aug. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026